Skip to main content
Signal8

BRIGHT and LanzaTech launch new partnership to accelerate carbon-to-value biotechnology in Europe

$LNZAPress releaseMay 6, 2026, 10:21 AM ET

LanzaTech entered a multi-year partnership with BRIGHT (the Novo Nordisk Foundation Biotechnology Research Institute at DTU) to advance carbon-to-value biotechnology in Europe. The agreement, running until April 2028, includes designing and installing a next-generation C1 biofoundry at DTU using LanzaTech's synthetic biology expertise.

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.